Peters Malte — SEC Form 4 filings
SEC reporting owner CIK 1876563. 8 Form 4 filings on record with FilingPulse; latest filed 2026-01-12.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-07 to 2026-01-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 54,348 shares, $47,526 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 29,176 shares @ $0.92 ($26,842) in HOOKIPA Pharma Inc., filed 2025-07-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| HOOKIPA Pharma Inc. (HOOK) | Chief Executive Officer, Director | 4 | — | 2 legs · 54,348 sh · $47,526 | 2 |
| Tango Therapeutics, Inc. (TNGX) | President & CEO, Director | 4 | — | — | 7 |
Form 4 filings — Peters Malte
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-12 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 350,000 @ $0 · Grant/award (A): 1,650,000 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-10-09 | 4 | HOOKIPA Pharma Inc. (HOOK) | Sale (S): 25,172 @ $0.82 | EDGAR |
| 2025-07-23 | 4 | HOOKIPA Pharma Inc. (HOOK) | Sale (S): 29,176 @ $0.92 | EDGAR |
| 2025-06-09 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2024-07-24 | 4 | HOOKIPA Pharma Inc. (HOOK) | Grant/award (A): 108,695 @ $0 | EDGAR |
| 2024-06-18 | 4 | HOOKIPA Pharma Inc. (HOOK) | Grant/award (A): 49,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1876563 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →